Table 2.
Data completeness and completion
Construct | Data completeness | Completion of PURPOSE‐T according to guidance | |||||||
---|---|---|---|---|---|---|---|---|---|
Number of items requiring completion | Expert nurse baseline assessment | Ward/Community nurse assessment | Expert nurse follow‐up assessment | Denominator (i.e. number of items expected to have been completed) | Completion of PURPOSE‐T according to guidance | Expert nurse baseline assessment | Ward/Community nurse assessment | Expert nurse follow‐up assessment | |
Step 1 Screening | |||||||||
Mobility | 1 of 4 | 99.6% (229/230) | 99.6% (229/230) | 100.0% (217/217) | All patients, as all were required complete step 1 mobility | Completed | 229 (99.6%) | 229 (99.6%) | 217 (100%) |
Not completed | 1 (0.4%) | 1 (0.4%) | 0 (0.0%) | ||||||
Total | 230 (100.0%) | 230 (100.0%) | 217 (100.0%) | ||||||
Skin status | 1 of 4 (if required) | 98.7% (78/79) | 96.6% (84/87) | 100.0% (63/63) | All patients for whom only the blue box was ticked for step 1 mobility | Appropriate completion (no mobility limitation) | 78 (33.9%) | 84 (36.5%) | 63 (29.0%) |
Inappropriate non‐completion (no mobility limitation) | 1 (0.4%) | 3 (1.3%) | 0 (0.0%) | ||||||
Appropriate non‐completion (mobility limitation) | 114 (49.6%) | 83 (36.5%) | 117 (53.9%) | ||||||
Inappropriate completion (mobility limitation) | 36 (15.7%) | 59 (25.7%) | 37 (17.1%) | ||||||
Completed but no mobility assessment | 0 (0.0%) | 1 (0.4%) | 0 (0.0%) | ||||||
Not completed and no mobility assessment | 1 (0.4%) | 0 (0.0%) | 0 (0.0%) | ||||||
Total | 230 (100.0%) | 230 (100.0%) | 217 (100.0%) | ||||||
Decision pathway allocated | 1 | 95.3% (41/43) | 85.7% (36/42) | 100.0% (38/38) | All patients for whom only the blue box was ticked for both step 1 mobility and step 1 skin status | ||||
Progression to step 2 | 195 | 197 | 182 | Appropriate progression to step 2 | 185 (80.4%) | 185 (80.4%) | 179 (82.5%) | ||
Inappropriate progression to step 2 | 9 (3.9%) | 12 (5.2%) | 3 (1.4%) | ||||||
Inappropriate non‐progression to step 2 | 0 (0.0%) | 1 (0.4%) | 0 (0.0%) | ||||||
Appropriate non‐progression to step 2 | 35 (15.2%) | 32 (13.9%) | 35 (16.1%) | ||||||
Step 2 completed but step 1 not completed | 1 (0.4%) | 0 (0.0%) | 0 (0.0%) | ||||||
Total | 230 (100.0%) | 230 (100.0%) | 217 (100.0%) | ||||||
Step 2 Full Assessment | |||||||||
Step 1 Mobility | 1 of 4 | 99.5% (194/195) | 99.5% (196/197) | 100.0% (182/182) | All patients who progressed to step 2, as all were required to complete step 1 mobility | ||||
Step 1 skin status | 1 of 4 (if required) | 97.7% (43/44) | 96.3% (52/54) | 100.0% (28/28) | All patients for whom only the blue box was ticked in step 1 mobility who progressed to step 2 | ||||
Analysis of independent movement | 1 of 5 | 99.0% (193/195) | 99.0% (195/197) | 98.9% (180/182) | All patients who progressed to step 2 | ||||
Sensory perception and response | 1 of 2 | 96.9% (189/195) | 94.9% (187/197) | 98.4% (179/182) | |||||
Current detailed skin assessment | 13 | 95.5% (2421/2535) | 95.3% (2440/2561) | 97.5% (2307/2366) | 13 (number of main skin sites) x number of patients who progressed to step 2 | ||||
Previous PU history | 1 of 2 | 99.0% (193/195) | 95.9% (189/197) | 98.4% (179/182) | All patients who progressed to step 2 | ||||
Previous PU details | At least 1 | 66.7% (40/60) | 54.7% (29/53) | 57.4% (35/61) | All patients reported to have a PU history | ||||
Perfusion | At least 1 | 97.9% (191/195) | 97.5% (192/197) | 97.3% (177/182) | All patients who progressed to step 2 | ||||
Nutrition | At least 1 | 99.0% (193/195) | 99.5% (196/197) | 97.8% (178/182) | |||||
Moisture | 1 of 3 | 99.5% (194/195) | 97.0% (191/197) | 96.7% (176/182) | |||||
Diabetes | 1 of 2 | 99.0% (193/195) | 95.9% (189/197) | 96.7% (176/182) | |||||
Decision pathway allocated | 1 of 3 | 100.0% (194/195) | 99.0% (195/197) | 100.0% (182/182) | |||||
Assessment Decision | |||||||||
Pathway allocated at step 1 or step 3 | Appropriate pathway | 226 (98.3%) | 219 (95.2%) | 215 (99.1%) | |||||
Inappropriate pathway | 4 (1.7%) | 10 (4.3%) | 2 (0.9%) | ||||||
No pathway selected | 0 (0.0%) | 1 (0.4%) | 0 (0.0%) | ||||||
Total | 230 (100.0%) | 230 (100.0%) | 217 (100.0%) |